Notes
Clopidogrel in Unstable angina to prevent Recurrent Events
The study was funded by Sanofi China.
Reference
Cui M, et al. A Cost-Effectiveness Analysis of Clopidogrel for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China. Advances in Therapy : 11 Jul 2016. Available from: URL: http://doi.org/10.1007/s12325-016-0375-9
Rights and permissions
About this article
Cite this article
Clopidogrel + aspirin cost effective for NSTEACS in China. PharmacoEcon Outcomes News 758, 15 (2016). https://doi.org/10.1007/s40274-016-3244-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3244-5